Literature DB >> 9706879

NGF induces transient but not sustained activation of ERK in PC12 mutant cells incapable of differentiating.

R Yaka1, A Gamliel, D Gurwitz, R Stein.   

Abstract

Activation of receptor tyrosine kinases stimulates a diverse array of cellular responses such as proliferation and differentiation. The first events in the signal transduction pathways mediated by different receptor tyrosine kinases are similar and include activation of the mitogen-activated protein kinase (MAPK) pathway and the induction of immediate early genes. The precise signaling pathways leading to each of the cellular responses mediated by receptor tyrosine kinases are still unknown, although it has been proposed that sustained activation of the MAPK pathway by receptor tyrosine kinases such as the nerve growth factor (NGF) receptor TrkA is sufficient to induce differentiation in PC12 cells. In the present study we examined the effect of NGF on mutant PC12 cells that were derived spontaneously in our cultures. NGF induced normal activation of immediate early genes in these cells, whereas the activation of some delayed response genes, as well as neurite outgrowth, was impaired. Furthermore, activation of the NGF-induced extracellular signal-regulated kinase (ERK) in these cells was transient, not sustained. These results support the hypothesis that sustained activation of ERK plays an important role in activating the induction of delayed response genes. However, sustained ERK activation is not a mandatory condition for the promotion of all the features of differentiated PC12 cells, as NGF could induce transcription of the delayed response gene, transin, in PC12 mutant cells. Taken together, our results suggest that NGF induces differentiation of PC12 cells via several signaling pathways, an important one of which is the MAPK pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706879     DOI: 10.1002/(sici)1097-4644(19980901)70:3<425::aid-jcb15>3.0.co;2-j

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Negative feedback regulation of Raf/MEK/ERK cascade after sublethal cerebral ischemia in the rat hippocampus.

Authors:  Q Cao; M Qian; X F Wang; B Wang; H W Wu; X J Zhu; Ying Wei Wang; J Guo
Journal:  Neurochem Res       Date:  2010-10-15       Impact factor: 3.996

2.  The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation.

Authors:  R Farias-Eisner; L Vician; A Silver; S Reddy; S A Rabbani; H R Herschman
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

3.  Protein kinase C activity is necessary for estrogen-induced Erk phosphorylation in neocortical explants.

Authors:  György Sétáló; Meharvan Singh; Imam S Nethrapalli; C Dominique Toran-Allerand
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

4.  Developmental regulation of neuronal KCa channels by TGFbeta 1: transcriptional and posttranscriptional effects mediated by Erk MAP kinase.

Authors:  L Lhuillier; S E Dryer
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

5.  Immunosuppressant FK506 induces neurite outgrowth in PC12 mutant cells with impaired NGF-promoted neuritogenesis via a novel MAP kinase signaling pathway.

Authors:  Yoshio Kano; Tsutomu Nohno; Toru Hasegawa; Rei Takahashi; Fukumi Hiragami; Kenji Kawamura; Michael K Iwama; Hirotoshi Motoda; Kanji Miyamoto
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

6.  Thrombin enhances NGF-mediated neurite extension via increased and sustained activation of p44/42 MAPK and p38 MAPK.

Authors:  Rania E Mufti; Krishna Sarker; Yan Jin; Songbin Fu; Jesusa L Rosales; Ki-Young Lee
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

7.  Investigating differential dynamics of the MAPK signaling cascade using a multi-parametric global sensitivity analysis.

Authors:  Jeongah Yoon; Thomas S Deisboeck
Journal:  PLoS One       Date:  2009-02-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.